John L. Wallwork
#159,274
Most Influential Person Now
John L. Wallwork's AcademicInfluence.com Rankings
John L. Wallworkmedical Degrees
Medical
#3174
World Rank
#3629
Historical Rank
Surgery
#265
World Rank
#324
Historical Rank
John L. Wallworkphilosophy Degrees
Philosophy
#9130
World Rank
#12640
Historical Rank
Logic
#6122
World Rank
#7605
Historical Rank
Download Badge
Medical Philosophy
Why Is John L. Wallwork Influential?
(Suggest an Edit or Addition)John L. Wallwork's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. (2005) (1223)
- Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension (1991) (1043)
- Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. (1991) (549)
- Risk factors for bronchiolitis obliterans: a systematic review of recent publications. (2002) (339)
- LONG-TERM TREATMENT OF PRIMARY PULMONARY HYPERTENSION WITH CONTINUOUS INTRAVENOUS EPOPROSTENOL (PROSTACYCLIN) (1984) (321)
- Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. (1982) (297)
- Life-supporting pig-to-primate renal xenotransplantation using genetically modified donors. (1998) (275)
- Consensus conference report: maximizing use of organs recovered from the cadaver donor: cardiac recommendations, March 28-29, 2001, Crystal City, Va. (2002) (227)
- Orthotopic heart transplantation in a transgenic pig-to-primate model. (1998) (218)
- Transbronchial lung biopsy for the diagnosis of rejection in heart-lung transplant patients. (1988) (199)
- Assessment of survival benefit after lung transplantation by patient diagnosis. (2002) (196)
- Cardiac transplantation in perspective for the future. Survival, complications, rehabilitation, and cost. (1982) (193)
- TISSUE EXPRESSION OF HUMAN COMPLEMENT INHIBITOR, DECAY‐ACCELERATING FACTOR, IN TRANSGENIC PIGS A POTENTIAL APPROACH FOR PREVENTING XENOGRAFT REJECTION (1995) (183)
- Long-term survival of nonhuman primates receiving life-supporting transgenic porcine kidney xenografts. (2000) (183)
- Treatment of primary pulmonary hypertension intravenous epoprostenol (prostacyclin). (1987) (173)
- Risk factors for obliterative bronchiolitis in heart-lung transplant recipients. (1991) (151)
- Impairment of pulmonary endothelium‐dependent relaxation in patients with Eisenmenger's syndrome (1990) (130)
- Toxoplasmosis in heart and heart and lung transplant recipients. (1989) (129)
- Immunohistochemical demonstration of human cardiac innervation before and after transplantation. (1990) (126)
- Transplant International Official Journal of the European Society for Organ Transplantation (1992) (124)
- Prostacyclin (epoprostenol) and heart-lung transplantation as treatments for severe pulmonary hypertension. (1993) (123)
- Life supporting function for over one month of a transgenic porcine heart in a baboon. (2000) (114)
- The effect of surgery with cardiopulmonary bypass on alveolar-capillary barrier function in human beings. (1985) (111)
- The use of home spirometry in detecting acute lung rejection and infection following heart-lung transplantation. (1990) (106)
- Three-month survival of HDAFF transgenic pig hearts transplanted into primates. (1999) (104)
- HEART-LUNG TRANSPLANTATION FOR CYSTIC FIBROSIS (1988) (103)
- The cough response to ultrasonically nebulized distilled water in heart-lung transplantation patients. (1989) (101)
- Cytomegalovirus infection in heart-lung transplant recipients: risk factors, clinical associations, and response to treatment. (1991) (97)
- Effect of Transgenic Expression of Human Decay—Accelerating Factor on the Inhibition of Hyperacute Rejection of Pig Organs (1997) (97)
- Prospective study of transbronchial biopsies in the management of heart-lung and single lung transplant patients. (1991) (95)
- TRANSPLANTATION OF LIVER, HEART, AND LUNGS FOR PRIMARY BILIARY CIRRHOSIS AND PRIMARY PULMONARY HYPERTENSION (1987) (95)
- EVIDENCE THAT LONG‐TERM SURVIVAL OF CONCORDANT XENOGRAFTS IS ACHIEVED BY INHIBITION OF ANTISPECIES ANTIBODY PRODUCTION (1992) (89)
- HERPES SIMPLEX VIRUS INFECTION IN HEART‐LUNG TRANSPLANT RECIPIENTS (1990) (88)
- The cumulative effect of acute rejection on development of cardiac allograft vasculopathy. (2005) (87)
- Heart-lung transplantation: better use of resources. (1988) (82)
- Maintenance triple immunosuppression with cyclosporin A, mycophenolate sodium and steroids allows prolonged survival of primate recipients of hDAF porcine renal xenografts (2003) (78)
- Selection and procurement of combined heart and lung grafts for transplantation. (1988) (77)
- Microvascular changes in small airways predispose to obliterative bronchiolitis after lung transplantation. (2004) (77)
- Life-supporting pig-to-baboon heart xenotransplantation. (1998) (77)
- Acute and chronic onset of bronchiolitis obliterans syndrome (BOS): are they different entities? (2001) (76)
- Cytomegalovirus infections in heart and heart and lung transplant recipients. (1988) (72)
- Technique and use of transbronchial biopsy in children and adolescents (1992) (70)
- Is obliterative bronchiolitis in lung transplantation associated with microvascular damage to small airways? (2006) (69)
- The radiographic appearances of infection and acute rejection of the lung after heart-lung transplantation. (1989) (68)
- Pulmonary vasodilation with prostacyclin in primary and secondary pulmonary hypertension. (1989) (68)
- The incidence of end-stage renal failure in 17 years of heart transplantation: a single center experience. (2002) (67)
- Lung Transplantation in patients with systemic diseases: an eleven-year experience at Papworth Hospital. (1996) (66)
- Neointimal smooth muscle cells in human cardiac allograft coronary artery vasculopathy are of donor origin. (2004) (66)
- Availability of transplantable organs from brain stem dead donors in intensive care units. (1991) (66)
- Effect of donor heart damage on survival after transplantation. (1989) (64)
- Survival and quality of life of cystic fibrosis patients before and after heart-lung transplantation. (1991) (64)
- Pig-to-primate cardiac xenotransplantation and cyclophosphamide therapy. (1997) (63)
- Maximizing use of organs recovered from the cadaver donor: Cardiac recommendations (2002) (62)
- Lung rejection and bronchial hyperresponsiveness to methacholine and ultrasonically nebulized distilled water in heart-lung transplantation patients. (1989) (62)
- Localisation of atrial natriuretic peptide immunoreactivity in the ventricular myocardium and conduction system of the human fetal and adult heart. (1988) (61)
- Bronchoalveolar lavage and transbronchial lung biopsy during acute rejection and infection in heart-lung transplant patients. Studies of cell counts, lymphocyte phenotypes, and expression of HLA-DR and interleukin-2 receptor. (1993) (60)
- Lung function associated with histologically diagnosed acute lung rejection and pulmonary infection in heart-lung transplant patients. (1990) (59)
- The importance of cytomegalovirus in heart-lung transplant recipients. (1989) (59)
- Transmission of hepatitis C virus by organ transplantation in the United Kingdom. (1994) (58)
- Bronchiolitis obliterans syndrome in heart-lung transplantation: surveillance biopsies. (1997) (58)
- Measurement of health-related quality of life before and after heart-lung transplantation. (1996) (55)
- Efficacy of pyrimethamine for the prevention of donor-acquired Toxoplasma gondii infection in heart and heart-lung transplant patients (1992) (55)
- Effects of inhaled capsaicin in heart-lung transplant patients and asthmatic subjects. (1993) (54)
- Toxoplasmosis in cardiac transplantation. (1986) (54)
- Hyperacute lung rejection in a pig-to-human transplant model: the role of anti-pig antibody and complement. (1997) (53)
- Malignant tumors after heart transplantation. (1990) (51)
- Randomized, trough blood cyclosporine concentration-controlled trial to compare the pharmacodynamics of Sandimmune and Neoral in de novo lung transplant recipients. (1999) (51)
- Selection and procurement of hearts for transplantation. (1984) (50)
- Donor heart preservation survey. (1992) (50)
- Pulmonary reflexes after human heart-lung transplantation. (1991) (49)
- Swan-Ganz catheter assessment of donor hearts: outcome of organs with borderline hemodynamics. (2001) (49)
- Combined transplantation of the heart, lung, and liver (2001) (49)
- Association between blood eosinophil counts and acute cardiac and pulmonary allograft rejection. (1998) (48)
- Heart-lung-liver transplantation. (1996) (47)
- Reduced endothelium-dependent relaxation of cystic fibrosis pulmonary arteries. (1989) (47)
- Cystic Fibrosis Liver Disease: To Transplant or Not to Transplant? (2007) (46)
- Clinical experience in the management of pulmonary opportunist infection and rejection in recipients of heart-lung transplants. (1988) (46)
- Early abdominal complications following heart and heart–lung transplantation (1991) (46)
- The histological changes in transbronchial biopsy after treatment of acute lung rejection in heart‐lung transplants (1990) (45)
- Xenograft adaptation is dependent on the presence of antispecies antibody, not prolonged residence in the recipient. (1992) (45)
- DISTANT PROCUREMENT OF ORGANS FOR CLINICAL HEART‐LUNG TRANSPLANTATION USING A SINGLE‐FLUSH TECHNIQUE (1987) (45)
- Some prognostic factors for the development of transplant-related coronary artery disease in human cardiac allografts. (1991) (45)
- Heart and lung transplantation in patients with end stage lung disease. (1987) (44)
- Diagnosis and treatment of allograft rejection in heart-lung transplant recipients. (1983) (43)
- Deposition of C4d and C3d in cardiac transplants: a factor in the development of coronary artery vasculopathy. (2010) (42)
- Expression of human decay accelerating factor or membrane cofactor protein genes on mouse cells inhibits lysis by human complement (1992) (42)
- Heart and lung transplantation for terminal cystic fibrosis: A 4½-year experience (1991) (41)
- Histopathology of cardiac xenograft rejection in the pig-to-baboon model. (2002) (41)
- Natural history of chronic rejection in heart-lung transplant recipients. (1990) (40)
- Transbronchial biopsies in children after heart-lung transplantation. (1990) (39)
- Acetylcholine and adenosine diphosphate cause endothelium-dependent relaxation of isolated human pulmonary arteries. (1990) (39)
- Early mortality after cardiac transplantation: should we do better? (2005) (39)
- Significance of donor transmitted disease in cardiac transplantation. (1985) (38)
- Histologic changes in heart-lung transplant recipients during rejection episodes and at routine biopsy. (1988) (37)
- CYCLOSPORIN AND INTRAVENOUS SULPHADIMIDINE AND TRIMETHOPRIM THERAPY (1983) (37)
- Airway mucosal bioelectric potential difference in cystic fibrosis after lung transplantation. (1989) (37)
- The effect of recipient lung size on lung physiology after heart-lung transplantation. (1989) (37)
- Cytomegalovirus antibody status of donor/recipient does not influence the incidence of bronchiolitis obliterans syndrome in lung transplantation. (2003) (35)
- Short- and long-term outcomes of combined cardiac and renal transplantation with allografts from a single donor. (2003) (35)
- Who waits longest for heart and lung transplantation? (1994) (35)
- Changes in Factor VIII Proteins After Cardiopulmonary Bypass in Man Suggest Endothelial Damage (1988) (35)
- Incidence of obliterative bronchiolitis after heart-lung transplantation in children. (1993) (34)
- Histologic prognostic indicators for the lung allografts of heart-lung transplants. (1990) (33)
- Serious interaction between cyclosporin A and sulphadimidine. (1986) (32)
- Pharmacokinetics of cyclosporine in heart and lung transplant candidates and recipients with cystic fibrosis and Eisenmenger's syndrome (1993) (32)
- Donor and recipient predicted lung volume and lung size after heart-lung transplantation. (1994) (32)
- Transbronchial biopsy has eliminated the need for endomyocardial biopsy in heart-lung recipients. (1988) (32)
- Angiogenesis occurs within the intimal proliferation that characterizes transplant coronary artery vasculopathy. (2005) (32)
- The diagnosis of lung rejection and opportunistic infection by transbronchial lung biopsy. (1987) (32)
- Incidence and aetiology of a raised hemidiaphragm after cardiopulmonary bypass. (1985) (32)
- Endothelial expression of human decay accelerating factor in transgenic pig tissue: a potential approach for human complement inactivation in discordant xenografts. (1995) (31)
- Eleven years on: a clinical update of key areas of the 1996 lung allograft rejection working formulation. (2007) (30)
- Tissue expression of human decay accelerating factor, a regulator of complement activation expressed in mice: a potential approach to inhibition of hyperacute xenograft rejection. (1993) (30)
- Altered Pharmacokinetics of Cyclosporin in Heart‐Lung Transplant Recipients with Cystic Fibrosis (1990) (30)
- Haemodialysis and haemofiltration on cardiopulmonary bypass. (1985) (30)
- Myocardial localization and isoforms of neural cell adhesion molecule (N-CAM) in the developing and transplanted human heart. (1990) (29)
- Interleukin 1 and Chronic Rejection: Possible Genetic Links in Human Heart Allografts (2002) (28)
- Splenectomy improves survival of HDAF transgenic pig kidneys in primates. (1999) (28)
- Short- and long-term outcomes of using pulmonary allograft donors with low Po2. (2005) (28)
- The natural history of obliterative bronchiolitis and occlusive vascular disease of patients following heart-lung transplantation. (1989) (27)
- Intravenous ganciclovir prophylaxis for cytomegalovirus in heart, heart-lung, and lung transplant recipients (1999) (27)
- Expression of human decay accelerating factor or membrane cofactor protein genes on mouse cells inhibits lysis by human complement. (1992) (27)
- Blood cyclosporin concentrations and the short-term risk of lung rejection following heart-lung transplantation. (1992) (27)
- Heart lung transplantation in a patient with end stage lung disease due to common variable immunodeficiency (1998) (26)
- Cyclosporine in vitro reduces endothelium-dependent relaxation to acetylcholine but does not affect relaxation to nitrovasodilators. (1990) (26)
- Xenotransplantation of pig organs transgenic for human DAF: an update. (1997) (26)
- Biopsy assessment of fifty hearts during transplantation. (1987) (26)
- Heart-lung transplantation for cystic fibrosis. 2: Outcome. (1991) (26)
- Metastatic endometrial stromal sarcoma masquerading as pulmonary lymphangioleiomyomatosis. (1999) (26)
- Cystic fibrosis. 5. The current state of lung transplantation for cystic fibrosis. (1991) (25)
- Successful heart-lung transplantation for cystic fibrosis. (1988) (25)
- Infection and reactivation with cytomegalovirus strains in lung transplant recipients. (1991) (25)
- Expression of human decay accelerating factor may protect pig lung from hyperacute rejection by human blood. (1997) (24)
- Does cytomegalovirus status influence acute and chronic rejection in heart transplantation during the ganciclovir prophylaxis era? (2003) (24)
- Heart-lung transplantation for cystic fibrosis. 1: Assessment. (1991) (24)
- Comparison between procalcitonin, serum amyloid A, and C-reactive protein as markers of serious bacterial and fungal infections after solid organ transplantation. (2001) (24)
- Cross-correlation of cyclosporine concentrations and biochemical measures of kidney and liver function in heart and heart-lung transplant recipients. (1990) (23)
- Graft-versus-host disease in lung transplantation: 4 case reports and literature review. (2003) (23)
- Epstein-Barr virus infection in heart and heart-lung transplant recipients: incidence and clinical impact. (1995) (23)
- The contribution of donor management and modified cold blood lung perfusate to post-transplant lung function. (1999) (22)
- A technique for perfusion of an isolated working heart to investigate hyperacute discordant xenograft rejection. (1993) (22)
- Cyclosporin A in cardiac transplantation: medium-term results in 62 patients. (1988) (22)
- Pulmonary function monitoring allows diagnosis of rejection in heart-lung transplant recipients. (1989) (22)
- 293: The 1-Year Follow-Up Results of the PROTECT Patient Population Using the Organ Care System (2008) (22)
- Successful simultaneous heart and kidney transplantation using the same donor (1988) (21)
- METABOLIC CHANGES IN THE AUTOTRANSPLANTED BABOON HEART (1984) (21)
- A detailed study of cytomegalovirus infections in the first 160 heart and heart/lung transplant recipients at Papworth Hospital, Cambridge, England. (1987) (20)
- Primary pulmonary hypertension: diagnosis, medical and surgical treatment. (1990) (20)
- Graft adaptation in hamster-to-rat cardiac xenografts. (1994) (20)
- Acute pancreatitis after cardiac transplantation (1983) (19)
- Effects of inhaled nebulized steroids (budesonide) on acute and chronic lung function in heart-lung transplant patients. (1995) (19)
- Cardiac transplantation: a review. (1995) (19)
- Early experience of heart-lung transplantation. (1989) (19)
- Leiomyosarcoma of the Retrohepatic Vena Cava Treated by Excision and Reconstruction With an Aortic Homograft: A Case Report and Review of Literature (2007) (19)
- Extended ganciclovir prophylaxis in lung transplantation. (2005) (19)
- Kidneys from HDAF transgenic pigs are physiologically compatible with primates. (1998) (19)
- Does heart transplantation confer survival benefit in all risk groups? (2005) (19)
- Risk factors for chronic rejection in heart and lungs--why do hearts and lungs rot? (1994) (19)
- 10: Prospective multi-center European trial to evaluate the safety and performance of the Organ Care System for heart transplants (PROTECT) (2007) (18)
- Prolonged survival of hamster to rat heart xenografts with cyclophosphamide therapy. (1992) (18)
- Consistent prolonged "concordant" survival of hamster-to-rat cardiac xenografts by inhibition of anti-species antibodies with methotrexate. (1993) (18)
- Pathology of unused donor lungs. (1993) (18)
- Survival of life-supporting HDAF transgenic kidneys in primates is enhanced by splenectomy. (1998) (17)
- The outcomes of lung transplantation in patients with bronchiectasis and antibody deficiency. (2005) (17)
- The rationale for xenotransplantation as a solution to the donor organ shortage. (1994) (17)
- Organs for transplantation. (1989) (17)
- Validation of impedance cardiography measurements of cardiac output during limited exercise in heart transplant recipients (1990) (16)
- Hyperacute rejection of rabbit hearts by human blood is mediated by the alternative pathway of complement. (1992) (16)
- Use of inhaled nitric oxide to reduce pulmonary hypertension after heart transplantation. (1993) (15)
- Massive lignocaine overdose during cardiopulmonary bypass. Successful treatment with cardiac pacing. (1984) (15)
- Cardiac transplantation with cyclosporine and steroids: medium and long-term results. (1988) (15)
- Relationship between Chronic Hypoxia and In Vitro Pulmonary Relaxation Mediated by Endothelium-Derived Relaxing Factors in Human Chronic Obstructive Lung Disease (1992) (15)
- Transplantation of the lung. (1990) (15)
- Diurnal variation in FEV1 after heart-lung transplantation. (1992) (14)
- Analysis of Responses to a Selective Phosphodiesterase III Inhibitor, SK&F 94120, on Isolated Myocardium, Including Human Ventricular Myocardium from “End‐Stage” Failure Patients (1987) (14)
- Concurrent cytomegalovirus and Coxsackie B virus infections in a heart-lung transplant recipient. (1986) (14)
- Blood cyclosporine concentrations and cytomegalovirus infection following heart transplantation. (1995) (14)
- Causes of exercise limitation after heart-lung transplantation. (1992) (14)
- Management following heart and lung transplantation: five years experience. (1990) (13)
- Surgical pathology of the thymus: 20 years' experience. (1986) (13)
- Primary angiosarcoma of the heart mimicking a left atrial myxoma. (1984) (13)
- Cyclosporine dosing in cystic fibrosis after transplantation. (1989) (13)
- Profound pulmonary hypertension characteristic of pig lung rejection by human blood is mediated by xenoreactive antibody independent of complement. (1995) (13)
- Impromidine is a partial histamine H2‐receptor agonist on human ventricular myocardium (1986) (13)
- Lack of association between cytomegalovirus infection of heart and rejection-like inflammation. (1989) (13)
- Comparison of survival by allocation to medical therapy, surgery, or heart transplantation for ischemic advanced heart failure. (2005) (13)
- Cystic fibrosis: a new challenge for cardiothoracic surgery. (1990) (12)
- A study of Epstein-Barr virus infections in heart and heart and lung transplant recipients. (1989) (12)
- Cytochemical demonstration of sites of hydrogen peroxide generation and increased vascular permeability in isolated pig hearts after ischaemia and reperfusion (1998) (12)
- Further studies on the natural history of obliterative bronchiolitis following heart-lung transplantation. (1991) (12)
- Heart-lung transplantation in children. (1990) (12)
- Heart and heart-lung transplantation (1989) (12)
- Are non-brain stem-dead cardiac donors acceptable donors? (2004) (11)
- Mechanisms governing the pace and character of pig heart-lung rejection by human blood. (1994) (11)
- Relative bioavailability of cyclosporin from conventional and microemulsion formulations in heart-lung transplant candidates with cystic fibrosis (2004) (11)
- Transplantation for end-stage lung disease. (1991) (11)
- Antibiotic prophylaxis for the prevention of donor-acquired Toxoplasma gondii infection in transplant patients. (1995) (11)
- The control of hyperacute rejection by genetic engineering of the donor species (1995) (11)
- RANDOMIZED TRIAL OF BLOOD EOSINOPHIL COUNT MONITORING AS A GUIDE TO CORTICOSTEROID DOSAGE ADJUSTMENT AFTER HEART TRANSPLANTATION1 (2000) (11)
- Distant procurement and preservation of heart-lung homografts. (1987) (11)
- Experience of cytomegalovirus infection in heart-lung transplant recipients. (1990) (11)
- Heart-lung transplantation at Papworth Hospital. (1989) (11)
- Acute leukaemoid reaction following cardiac surgery (2007) (11)
- Effects of the immunosuppressant cyclosporine on the circulation of heart transplant recipients. (1991) (11)
- Inhibition of rejection of hamster-to-rat heart xenografts. (1992) (10)
- Management of rejection in heart transplant recipients: does moderate rejection always require treatment? (1990) (10)
- Bronchiolitis obliterans syndrome (BOS) following heart‐lung transplantation (1996) (10)
- Aspects of immunosuppression for cardiac transplantation (1982) (10)
- Biopsy assessment of myocardial preservation in 160 human donor hearts. (1988) (10)
- Immunosuppression, eotaxin and the diagnostic changes in eosinophils that precede early acute heart allograft rejection. (2004) (9)
- Efficacy of pyrimethamine for the prevention of donor‐acquired Toxoplasma gondii infection in heart and heart‐lung transplant patients (1992) (9)
- Ventilatory compensation for changes in posture after human heart-lung transplantation. (1989) (9)
- Activation of the alternative pathway of complement in hyperacute xenograft rejection of rabbit hearts by human blood. (1993) (9)
- The natural history of chronic rejection in heart-lung transplant recipients: a clinical, pathological, and physiological review of 29 long-term survivors. (1990) (9)
- Pharmacodynamics of cyclosporine in heart and heart-lung transplant recipients. I: Blood cyclosporine concentrations and other risk factors for cardiac allograft rejection. (1996) (9)
- Pig lungs are susceptible to hyperacute rejection by human blood in a working ex vivo heart-lung model. (1994) (8)
- Paediatric incidence of acute rejection and obliterative bronchiolitis: a comparison with adults (1994) (8)
- White blood cells and platelets are integral to the hyperacute rejection of the pig heart by human blood. (1995) (8)
- Acute pulmonary hypertensive crisis in a patient with primary pulmonary hypertension treated by both epoprostenol (prostacyclin) and nitroprusside. (1991) (8)
- Bronchoalveolar lavage lymphocytes in relation to transbronchial lung biopsy in heart-lung transplants. (1990) (8)
- Storage and transport of heart and heart-lung donor organs with inflatable cushions and eutectoid cooling. (1988) (8)
- Pig-to-human xenograft reaction: is haemostatic activation dependent on the presence of anti-pig antibodies or complement? (1994) (8)
- Heart-lung transplantation for pneumothorax in cystic fibrosis. (1989) (8)
- Japanese study of kidney transplantation: 1. Results of early phase II study. (1992) (7)
- Prolongation of survival of rat heart xenografts in C3-deficient guinea pigs. (1994) (7)
- 'Rejection or infection' predictive value of T-cell subject ratio, before and after heart transplantation. (1985) (7)
- PROLONGED SURVIVAL OF HDAF TRANSGENIC PIG KIDNEYS IN PRIMATES (1998) (7)
- Ethical considerations in clinical cardiac xenografting. (1993) (7)
- Cardiac surgery for patients aged 65 years and older: a long term survival analysis. (1988) (7)
- APT070 inhibits complement activation during in vitro cardiopulmonary bypass. (2006) (7)
- Value of culture of biopsy material in diagnosis of viral infections in heart-lung transplant recipients. (1990) (6)
- Use of a double-lumen tracheostomy tube after single lung transplantation. (1992) (6)
- Analysis of hyperacute rejection of pig hearts by human blood using an ex vivo perfusion model. (1994) (6)
- Surgery for Congenital Heart Defects (2006) (6)
- Heart-lung transplantation: indications and technique. (1992) (6)
- Heart and lung transplantation from poisoned braindead donors: A 10-year United Kingdom experience (1999) (6)
- Transplantation of lungs. (1989) (6)
- PROLONGED SURVIVAL OF ORTHOTOPIC CARDIAC XENOGRAFTS IN AN hDAF TRANSGENIC PIG-TO-BABOON MODEL (1999) (6)
- Transbronchial biopsy after lung transplantation. (1991) (6)
- Cyclosporine in heart transplant recipients: an exercise study of vasopressor effects. (1992) (5)
- The use of heart-lung transplantation in management of terminal respiratory complications of cystic fibrosis. (1990) (5)
- Combined heart-lung transplantation from a donation after circulatory death donor. (2020) (5)
- Xenotransplantation—2000 (2000) (5)
- Intravenous ganciclovir prophylaxis for cytomegalovirus in heart, heart‐lung, and lung transplant recipients (1999) (5)
- A comparison of the performance of pig hearts perfused with pig or human blood using an ex-vivo working heart model. (1994) (5)
- Thoracic organ transplantation at Papworth Hospital. (1996) (5)
- Early graft function after heart-lung transplantation. (1990) (5)
- Blood cyclosporin concentrations but not doses correlate with acute changes in renal function following heart and heart-lung transplantation. (1992) (5)
- [Xenotransplantation of hDAF-transgenic swine hearts]. (1999) (5)
- Retransplantation in heart-lung recipients with obliterative bronchiolitis. (1995) (4)
- Airway complications after lung transplantation: is there a left-sided predilection? (1995) (4)
- Neutrophil elastase and obliterative bronchiolitis (1994) (4)
- Paediatric Heart and Heart–Lung Transplantation (2006) (4)
- Use of inhaled nitric oxide to reduce pulmonary hypertension after heart transplantation. (1993) (4)
- Heart and heart-lung transplantation Papworth Hospital 1979 to 1987. (1987) (4)
- The use of allopurinol in the inhibition of obliterative bronchiolitis of the transplanted lung. (1992) (4)
- The characteristic histological changes associated with rejection in heart-lung transplant recipients. (1989) (4)
- Genetic engineering of the donor species to control hyperacute xenograft rejection. (1995) (3)
- Perfusion of rabbit hearts with human blood results in immediate graft thrombosis, which is temporally distinct from hyperacute rejection. (1992) (3)
- Successful use of repeated transbronchial lung biopsies in a patient with multiple opportunistic infections. (1989) (3)
- Activation of the alternative pathway of complement is an important component of hyperacute rejection of rabbit hearts by human blood. (1992) (3)
- Phylogenetic disparity does not always equate with hyperacute rejection in xenotransplantation. (1994) (3)
- Late pulmonary haemodynamic changes in heart-lung transplantation. (1992) (3)
- Failure of whole blood cyclosporine levels to provide a reliable measure of immunosuppression in clinical heart and heart/lung transplantation. (1988) (3)
- Heart and Lung Transplantation (1988) (3)
- Intensive care management of children following heart and heart-lung transplantation (2005) (3)
- A possible role for mixed venous blood changes in the hyperventilation of exercise in heart-lung transplant recipients. (1990) (3)
- Evaluation of the International Society for Heart Transplantation (ISHT) grading of pulmonary rejection in 100 consecutive biopsies. (1992) (3)
- [Heart-lung transplantation. Experience of Papworth Hospital. Apropos of 24 surgical cases]. (1988) (2)
- 183: Everolimus reduces intimal proliferation in an ex-vivo model of vascular injury (2006) (2)
- Twenty-five years of heart transplantation at Papworth Hospital: Changes in factors influencing short- and long-term patient survival over time (2008) (2)
- Transplanting Organs from Pigs Transgenic for a Single Human Complement Regulatory Protein (2001) (2)
- Eotaxin and prednisolone concentrations regulate the mobilisation of peripheral blood eosinophils preceding heart allograft rejection. (2001) (2)
- Histological grading of acute lung rejection on transbronchial biopsy helps predict long-term outcome of heart-lung transplants. (1990) (2)
- Pharmacodynamics of cyclosporine in heart and heart-lung transplant recipients. II: Blood cyclosporine concentrations and other risk factors for lung allograft rejection. (1996) (2)
- Cyclosporin and Exercise - Induced Hypertension (1987) (2)
- Successful outcome in lung transplant recipients who receive organs from donors with rapid onset fatal asthma (2003) (2)
- Transgenic pigs as potential donors for xenografts (1994) (2)
- Heart-lung transplantation: graft function postoperatively. (1990) (2)
- Domino heart transplantation: 10 years experience (1999) (2)
- Postoperative Cardiac Surgical Care (1992) (2)
- Cytomegalovirus disease as a possible etiologic factor for early atherosclerosis. (1999) (2)
- Heart and lung transplantation. (1997) (2)
- Update on success with heart lung transplantation for cystic fibrosis. (1989) (2)
- Changes in the coronary artery adventitial microvascular density may be involved in the pathogenesis of coronary artery vasculopathy (2003) (2)
- Cardiopulmonary xenotransplantation: The past, the present and future prospects (1995) (2)
- The Physiology of Heart-Lung Transplantation in Humans (1990) (2)
- Design and evaluation of a computer tool to aid early management of cyclosporine therapy after heart and heart-lung transplantation. (1994) (2)
- The use of 111in-labeled lymphocyte imaging to evaluate graft rejection following cardiac transplantation in dogs (2004) (2)
- Early graft function following heart and lung transplantation (1989) (2)
- Exercise increases the release of atrial natriuretic peptide in heart transplant recipients (2004) (1)
- The heart-transplanted patient in the intensive care unit: last news before the millennium (1999) (1)
- Post-operative management of the lung transplant patient (1995) (1)
- Mechanical ventilation and lung transplantation (1994) (1)
- Complement regulators are down regulated by ischemia reperfusion in heart transplantaion (2005) (1)
- AbstractAre non-brain-stem-dead cardiac donors acceptable donors? (2002) (1)
- The use of allopurinol in the inhibition of obliterative bronchiolitis of the transplanted lung (1992) (1)
- Diagnostic accuracy of coronary angiography and risk factors for post-heart transplant Coronary Artery Vasculopathy (CAV) (2003) (1)
- Thoracic organ transplantation at Papworth Hospital. (1999) (1)
- Xenograft rejection in the guinea pig. (1994) (1)
- 404: Twenty-five years of heart transplantation at a single centre: Changes in factors influencing short- and long-term survival over time (2007) (1)
- Transplantation of the lungs. (1989) (1)
- Use of lung biopsies in lung transplant recipients. (1990) (1)
- Japanese study of FK 506 on kidney transplantation: 2. Follow-up study of FK 506-treated patients. (1992) (1)
- Cardiopulmonary bypass does not increase the morbidity associated with lung transplantation for chronic obstructive airway disease (2003) (1)
- Survival benefit of heart transplantation in high risk donors and recipients (2003) (1)
- Origin of neointimal smooth muscle cells in human cardiac allograft coronary artery vasculopathy (2002) (1)
- Postoperative Management, Surgical Complications, Diagnosis and Management of Acute Rejection (1990) (1)
- THE USE OF INDIUM-111 LABELED LYMPHOCYTE IMAGING TO EVALUATE GRAFT REJECTION FOLLOWING CARDIAC TRANSPLANTATION IN DOGS (1981) (1)
- Patient factors influencing waiting time to heart transplant in the UK and Republic of Ireland (2003) (1)
- Reaudit of the accuracy of referral and histopathological explant diagnoses in lung transplantation. Have we improved (2002) (1)
- Principles of lung allocation (1997) (1)
- Perfusion of rabbit hearts with human blood results in immediate graft thrombosis, a temporally distinct component of hyperacute rejection. (1992) (1)
- The Ethics of Domino Heart Transplantation (1991) (1)
- Myocardial preservation for transplantation: A study of 300 human donor hearts (1990) (1)
- The Management of Cytomegalovirus Infection in Heart-Lung Transplant Recipients (1993) (1)
- Heart-lung transplantation. (1982) (1)
- Combined heart and lung transplantation: the Papworth experience (1991) (1)
- Colonic perforation following cardiac transplantation (1989) (1)
- Transvenous lung biopsy: a new technique. (1987) (1)
- Providing donor organs for transplantation (1988) (0)
- The TGF-β signalling pathway is activated in coronary artery vasculopathy (2004) (0)
- Evaluation of the International Society for Heart Transplantation (ISHT) grading of pulmonary rejection in 100 consecutive biopsies (1992) (0)
- Atrioventricular orthotopic heart transplantation: long term follow up of a prospective randomised clinical trial (2003) (0)
- Perfusion of rabbit hearts with pig blood results in complement mediated hyperacute xenograft rejection. (1992) (0)
- Changes in Factor VIII Proteins during and after Cardiopulmonary Bypass in Man (1986) (0)
- [Clinical applications of the heart-lung transplant. Clinical results 5 years after the start of the program at Papworth]. (1989) (0)
- Comparison of Direct Fick and Thermodilution Measurements of Cardiac Output in Primary Pulmonary Hypertension and Chronic Obstructive Airways Disease (1985) (0)
- Matching of Donor and Recipient Lung Size in Heart-Lung Transplantation (1988) (0)
- Pulmonary hypertension. (1987) (0)
- Activation of the alternative pathway of complement is an important component of hyperacute rejection of rabbit hearts by human blood (1992) (0)
- The Effects of Capsaicin on the Denervated and Asthmatic Lung (1990) (0)
- Perfusion of rabbit hearts with pig blood results in complement mediated hyperacute xenograft rejection (1992) (0)
- Bioelectrical Potential Difference across the Respiratory Mucosa following Heart-Lung Transplantation (1988) (0)
- Long term results of the domino procedure from cystic fibrosis live donors (2003) (0)
- Heart and Lung Transplantation: Present and Future. (1988) (0)
- Comparative effects of long-term treatment with prostacyclin and its analogue, iloprost, on exercise tolerance of patients with primary pulmonary hypertension (1990) (0)
- 407: Comparison of Outcome Following Heart/Lung Transplantation for Chronic Thromboembolic Pulmonary Hypertension and Idiopathic Pulmonary Arterial Hypertension (2010) (0)
- 197: Deposition of C4d in heart transplants: A factor in the development of CAV? (2007) (0)
- Changes in Glucose Oxidation by the Auto-Transplanted Heart (1983) (0)
- Effect of Exercise on Circulating Atrial Naturetic Factor in Heart Transplant Recipients (1988) (0)
- 33 Serial Phenotyping Identifies Circulating B Cell Signatures within Six Months of Cardiac Transplantation (2011) (0)
- Invited commentary:H. Jellinek et al.: “Alveolar dead space ventilation during bilateral lung transplantation determined by the arterial to end-tidal CO2 tension difference” — (Acta Chir. Austriaca 1994; 26:47–51) (1994) (0)
- rejections combination of immunosuppressive substances for the treatment or prevention of graft (2000) (0)
- David J. G. White, PhD, FRCPath (2017) (0)
- Quantitative birefringence studies before, during and after cardiac transplantation (1984) (0)
- 419: Initial cyclosporin C2 monitoring following lung transplantation provides long-term clinical benefits: A prospective randomised study (2007) (0)
- Double lung transplantation via median sternotomy and with cardiopulmonary bypass is safe and without adverse clinical outcome (2003) (0)
- Cardiovascular effects of cyclosporine in heart transplant recipients. (1990) (0)
- Prolonged survival of cardiac xenografts between widely divergent species: bird to mammal. (1995) (0)
- Perfusion of rabbit hearts with human blood results in immediate graft thrombosis, a temporally distinct component of hyperacute rejection (1992) (0)
- A post mortem audit of deaths occurring beyond 30 days following heart-lung transplantation (1999) (0)
- Short and long term outcomes using marginal pulmonary allograft donors (2003) (0)
- Localisation ofatrial natriuretic peptide immunoreactivity intheventricular myocardiumand conduction systemofthehumanfetal andadultheart (1988) (0)
- Cardiopulmonary preservation. (1988) (0)
- Fewer centers will increase quality and safety in cardiothoracic transplantation (2007) (0)
- 53 BLOOD EOSINOPHILS, ORAL STEROID DOSAGE AND ACUTE HEART ALLOGRAFT REJECTION (1997) (0)
- Randomised trial of cyclosporin C0 vs. C2 monitoring in de novo lung transplant recipients: Interim results (2005) (0)
- 411: 25 Years of Heart & Lung Transplantation: Past, Present & Future (2010) (0)
- 201 PHARMACO-KINETICS AND -DYNAMICS OF NEORAL AND SANDIMMUN AFTER LUNG TRANSPLANTATION (1997) (0)
- Transmyocardial laser revascularisation in clinical practice (1999) (0)
- Transvenous lung biopsy in the pig. (1986) (0)
- Is cyclosporine's nephrotoxicity related to its immunosuppressive effectiveness? (1985) (0)
- Immunological aspects of heart-lung transplantation (1991) (0)
- Systemic vasculitis complicating pig to primate xenotransplantation. (2001) (0)
- pulmonary hypertension . transplantation as treatments for severe Prostacyclin ( epoprostenol ) and heart-lung (0)
- 450: Characterization of IgM and Complement within CAV Lesions (2010) (0)
- Inhibition of rejection of hamster‐to‐rat heart xenografts (1992) (0)
- Histopathology of rejection in the pig-to-primate cardiac xenograft model. (2001) (0)
- [Lung transplantation at the Papworth Hospital: 9-year experience]. (1999) (0)
- Contents, Vol. 58, Supplement 1, 1991 (1991) (0)
- Donor management tactics for cardiothoracic transplantation (2000) (0)
- fibrosis . 2 : Outcome . Heart-lung transplantation for cystic (2007) (0)
- Distribution of collagen subtypes and matrix metalloproteinases in coronary artery vasculopathy (2003) (0)
- [Combination heart-lung transplantation in children: 4-year experience in London]. (1993) (0)
- Proteins of the respiratory tract after heart-lung transplantation. (1990) (0)
- The loss of function of Fas-L may contribute to the accelerated nature of transplant coronary artery vasculopathy (2002) (0)
- Thin-Section CT and the Solitary Pulmonary Nodule (2017) (0)
- Obliterative bronchiolitis of the transplanted lung. (1992) (0)
- In Vitro Pulmonary Endothelium-Dependent Vasorelaxation in Cystic Fibrosis (1989) (0)
- 114: Prolonged postoperative mechanical ventilation of more than twenty-four hours (PPMV) following lung transplantation: Incidence, indications and outcomes (2007) (0)
- Management of heart-lung transplant patients. (1990) (0)
- Difficulty in managing cyclosporin C2 monitoring in de novo lung transplant recipients (2004) (0)
- 235: Transforming growth factor-β (TGF-β) and Smad mediated epithelial mesenchymal transition (EMT) in obliterative bronchiolitis (OB) (2007) (0)
- Prolonged non-invasive ventilatory support prior to pulmonary transplantation does not affect postoperative outcome (2003) (0)
- Heart and lung transplantation : Transplantation in the 21st century : Increasing demands-dwindling resources (1997) (0)
- The Effect of Prostacyclin on Alveolar-Capillary Membrane Permeability following Cardiopulmonary By-Pass (1984) (0)
- Pediatric heart transplantation. Reply (1990) (0)
- 314: Long-term results of combined heart-lung transplantation: Analysis of 325 first transplants over twenty-two years at a single centre (2007) (0)
- The influence of chronic pulmonary hypertension on pulmonary valve leaflet remodelling (1995) (0)
- Surgical pathology ofthethymus: 20years' experience (1986) (0)
This paper list is powered by the following services:
